N
Power Law company profile
Nektar Therapeutics
Biotech & Life Sciences · San Carlos, United States · Founded 1990 · IPO 1994 Thoroughbred
Valuation
$2.71B
Market cap · May/2026
Revenue
$55M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Nektar Therapeutics mafia
Startups founded by Nektar Therapeutics alumni
Former Nektar Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
RayzeBioEst. 2020
Deborah Charych, Ph.D.United StatesSignal score91
RezoluteEst. 2010
Nevan Charles ElamUnited StatesSignal score83
CognoaEst. 2013
Brent VaughanUnited StatesSignal score79
Aeovian PharmaceuticalsEst. 2012
Stelios TzannisUnited StatesSignal score74
Cadence HealthEst. 2016
Samantha MillerUnited StatesSignal score72
InCarda TherapeuticsEst. 2009
NRNarsi RUnited States
Signal score69
Biota TechnologyEst. 2013
Robert ChessUnited StatesSignal score68
Unchained LabsEst. 2014
Tim HarknessUnited StatesSignal score64
Pearl TherapeuticsEst. 2006
Sarvajna DwivediUnited StatesSignal score58
Global footprint
Where Nektar Therapeutics has talent and traffic
Workforce by country
15
countries with
team presence
team presence
🇺🇸 United States83.3%
🇮🇳 India10.5%
🇨🇦 Canada0.9%
🇬🇧 United Kingdom0.9%
🇮🇹 Italy0.5%
Web traffic by country
51K
monthly visits
across markets
across markets
🇺🇸 United States20.6%
🇬🇧 United Kingdom5.3%
🇨🇦 Canada4.5%
🇪🇸 Spain2.4%
🇫🇷 France2.2%
Market sentiment
What the market is saying about Nektar Therapeutics
An AI-synthesized read of the highest-engagement posts about Nektar Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nektar Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.